BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SYK, P43405, 6850, ENSG00000165025 AND Prognosis
5 results:

  • 1. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
    Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
    Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin].
    Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
    Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
    Park GB; Chung YH; Kim D
    Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Spleen Tyrosine Kinase Confers Paclitaxel Resistance in ovarian cancer.
    Wei W; Birrer MJ
    Cancer Cell; 2015 Jul; 28(1):7-9. PubMed ID: 26175410
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.